Overview

Update
IPO / Stock
Went Public on Jun 22, 2015 / NASDAQ:NTRA
Total Equity Funding
$152.1M in 6 Rounds from 12 Investors
Headquarters:
Redwood City, California
Description:
Natera develops tests ranging from pre-implantation genetic diagnosis for IVF to advances in the field of non-invasive prenatal testing.
Founders:
Categories:
Biotechnology, Health Diagnostics, Medical
Website:
http://www.natera.com
Social:

Company Details

Update

Natera is driven by a passion for elevating the science and utility of prenatal testing. The advent of the Information Age has created a paradigm shift in the fields of computing and informatics. Surprisingly, medical diagnostics have been slow to integrate these advances into genetic testing.

Funding Rounds (7) - $154.1M

Update
DateAmount / RoundValuationLead InvestorInvestors
Apr, 2015$55.5M / Series F7
May, 2013$54.6M / Series E6
Jan, 2012$20M / Series D3
Apr, 2011$2M / Grant1
Nov, 2010$12M / Series C1
Jan, 2009$6M / Series B3
Dec, 2008$4M / Series A2

Current Team (14)

Update

Board Members and Advisors (2)

Update

Offices/Locations (4)

Update
  • Boston Office

    57 Pleasant Street

    Newton Center

    Boston, Massachusetts 02459

    United States

  • Headquarters

    201 Industrial Road,

    Suite 410

    San Carlos, California 94070

    United States

  • New York Office

    322 West 57th Street

    20th Floor

    New York, New York 10019

    United States

  • Redwood City Office

    2686 Middlefield Road

    Suite C

    Redwood City, California 94063

    United States

Past Team (1)

Update

Images (2)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos